Challenges of rapamycin repurposing as a potential therapeutic candidate for COVID-19: implications for skeletal muscle metabolic health in older personsCOVID-19의 잠재적인 치료 후보로 라파마이신 용도 변경의 도전: 노인의 골격근 대사 건강에 대한 영향Editorial Published on 2022-06-012022-09-11 Journal: American journal of physiology. Endocrinology and [Category] COVID19(2023년), SARS, 신약개발, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Administered administration affected aging anabolic anabolic resistance antiviral medication attenuate bed rest block blunting causative agent Cell cell growth challenge clinical trial coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 hospitalization death Decline demonstrated downstream drug Drug repurposing Effect effective effective vaccine Effective vaccines effectors greater growth Health healthy Hospitalization Human implication lack master regulator Mortality MPS mTOR muscle loss muscle mass muscle protein muscle protein synthesis muscle protein synthesis. Older pandemic Pandemics Rapamycin reduced resulting risk SARS-CoV-2 sedentariness Severe infection Skeletal muscle Spread susceptible the disease therapeutic with COVID-19 younger patients [DOI] 10.1152/ajpendo.00064.2022 PMC 바로가기 [Article Type] Editorial